NCT00489099View on ClinicalTrials.gov

A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)

PHASE3CompletedINTERVENTIONAL
Enrollment

860

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Hepatitis B Infection
Interventions
BIOLOGICAL

V232 Modified Process Hepatitis B Vaccine: Lot A

BIOLOGICAL

V232 Modified Process Hepatitis B Vaccine: Lot B

BIOLOGICAL

V232 Modified Process Hepatitis B Vaccine: Lot C

BIOLOGICAL

V232 Current Process Hepatitis B Vaccine

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00489099 - A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054) | Biotech Hunter | Biotech Hunter